Examples of using Interferon beta in English and their translations into Finnish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
Interferon beta has a potential for causing severe liver injury.
The following side effects were reported for interferon beta frequency not known.
Interferon beta 1-a is a form of a protein that is naturally produced by the body.
Hypothyroidism and hyperthyroidism have been observed with the use of interferon beta products.
Interferon beta is produced by various cell types including fibroblasts and macrophages.
As rodents do not react to human interferon beta, repeated dose studies were carried out with rhesus monkeys.
Interferon beta may cause flu-like symptoms such as headache, fever, chills, muscle and joint pains, fatigue and nausea.
Hypersensitivity to natural or recombinant interferon beta or peginterferon or to any of the excipients listed in section 6.1.
Rebif must not be used in people who are hypersensitive(allergic)to natural or recombinant interferon beta, or any of the other ingredients.
The replacement interferon beta-1a acts in the same way as naturally produced interferon beta.
Patients with a history of hypersensitivity to natural or recombinant interferon beta, human albumin or to any excipients listed in section 6.1.
The replacement interferon beta-1b acts in the same way as naturally produced interferon beta.
Patients should be informed of the most frequent adverse reactions associated with interferon beta administration, including symptoms of the flu-like syndrome see section 4.8.
Patients with a history of hypersensitivity to natural or recombinant interferon beta, human albumin or to any of the excipients listed in section 6.1.
Natural interferon beta and AVONEX(interferon beta-1a) are glycosylated and have a single N-linked complex carbohydrate moiety.
The exact way that Rebif works in MS is not yet known but interferon beta seems to calm the immune system down and prevent relapses of MS.
Decreased peripheral blood counts in all cell lines, including rare pancytopenia and severe thrombocytopenia, have been reported in patients receiving interferon beta.
Hypersensitivity to natural or recombinant interferon beta, human albumin or to any of the excipients listed in section 6.1.
Renal and urinary disorders Caution should be used and close monitoring considered when administering interferon beta to patients with severe renal failure.
If you are allergic to natural or recombinant interferon beta, human albumin or any of the other ingredients of this medicine listed in section 6.
The gradual increase of the Rebif dose during the initial 4 weeks of treatment is recommended to reduce interferon beta side effects when starting treatment.
Direct comparative data for Plegridy versus non- pegylated interferon beta or data on efficacy of Plegridy after switching from a non-pegylated interferon beta are not available.
Betaferon should not be used in people who have a history of hypersensitivity(allergy)to natural or recombinant interferon beta, human albumin or any of the other ingredients.
Based on the clinical data related to concomitant administration of teriflunomide with interferon beta or with glatiramer acetate, no waiting period is required when initiating teriflunomide after interferon beta or glatiramer acetate orwhen starting interferon beta or glatiramer acetate, after teriflunomide.